EGFR Mutation Analysis in Non-small Cell Lung Carcinoma Patients: A Liquid Biopsy Approach
In conclusion, our data suggest that evaluation ofEGFR mutation from cfDNA samples is practicable as a non-invasive tool in patients with advanced-stage of lung cancer.
Source: Indian Journal of Clinical Biochemistry - Category: Biochemistry Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Carcinoma | India Health | Lung Cancer | Non-Small Cell Lung Cancer | Smokers | Statistics | Study